Total Payments
$404.85
2024 Payments
$128.61
Companies
6
Transactions
18
Medicare Patients
935
Medicare Billing
$47,950
Payment Breakdown by Category
Food & Beverage$404.85 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $404.85 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $151.00 | 3 | $0 (2024) |
| Genentech USA, Inc. | $125.19 | 11 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $78.47 | 1 | $0 (2021) |
| PFIZER INC. | $17.35 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $16.86 | 1 | $0 (2023) |
| Myriad Women's Health, Inc. | $15.98 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $128.61 | 2 | ABBVIE INC. ($128.61) |
| 2023 | $72.58 | 4 | ABBVIE INC. ($22.39) |
| 2022 | $13.00 | 1 | Genentech USA, Inc. ($13.00) |
| 2021 | $190.66 | 11 | Genentech USA, Inc. ($112.19) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $103.59 | General |
| Category: IMMUNOLOGY | ||||||
| 05/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/09/2023 | Myriad Women's Health, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: ONCOLOGY | ||||||
| 03/22/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/12/2022 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Virology & Specialty Care | ||||||
| 11/23/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: Virology & Specialty Care | ||||||
| 10/19/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: Virology & Specialty Care | ||||||
| 09/16/2021 | Teva Pharmaceuticals USA, Inc. | ArmonAir Digihaler (Drug), ProAir Digihaler, AirDuo RespiClick | Food and Beverage | In-kind items and services | $78.47 | General |
| Category: Respiratory | ||||||
| 03/08/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: Virology & Specialty Care | ||||||
| 02/18/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Virology & Specialty Care | ||||||
| 02/16/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $10.45 | General |
| Category: Virology & Specialty Care | ||||||
| 02/16/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $2.88 | General |
| Category: Virology & Specialty Care | ||||||
| 02/04/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Virology & Specialty Care | ||||||
| 02/01/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Virology & Specialty Care | ||||||
| 01/28/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Virology & Specialty Care | ||||||
| 01/21/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $6.99 | General |
| Category: Virology & Specialty Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 303 | 332 | $50,498 | $13,075 |
| 2022 | 6 | 126 | 139 | $23,472 | $7,331 |
| 2021 | 8 | 252 | 256 | $27,710 | $13,255 |
| 2020 | 6 | 254 | 258 | $35,900 | $14,288 |
Total Patients
935
Total Services
985
Medicare Billing
$47,950
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 91 | 96 | $19,776 | $5,193 | 26.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 44 | 44 | $11,176 | $2,464 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 28 | $8,176 | $2,391 | 29.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 22 | 22 | $1,672 | $761.64 | 45.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 22 | 43 | $2,881 | $697.46 | 24.2% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 23 | 23 | $3,013 | $667.04 | 22.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 28 | 29 | $2,291 | $544.18 | 23.8% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 15 | 15 | $1,005 | $243.00 | 24.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 12 | $408.00 | $70.00 | 17.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 19 | 20 | $100.00 | $44.00 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 52 | $10,712 | $3,382 | 31.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $5,588 | $1,665 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 11 | $3,212 | $1,028 | 32.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 13 | 14 | $1,064 | $484.68 | 45.6% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 18 | 18 | $1,422 | $414.65 | 29.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 11 | 22 | $1,474 | $357.16 | 24.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 90 | 93 | $11,160 | $6,111 | 54.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 23 | $4,370 | $2,077 | 47.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 26 | 26 | $4,420 | $1,700 | 38.5% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 28 | 28 | $3,360 | $1,332 | 39.7% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 32 | 32 | $1,920 | $1,131 | 58.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 12 | $1,080 | $462.01 | 42.8% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 22 | 22 | $1,100 | $397.48 | 36.1% |
| 81003 | Automated urinalysis test | Office | 2021 | 19 | 20 | $300.00 | $45.00 | 15.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 87 | 91 | $10,815 | $5,170 | 47.8% |
About Amy Lafontaine, P.A
Amy Lafontaine, P.A is a Physician Assistant healthcare provider based in North Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659346104.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy Lafontaine, P.A has received a total of $404.85 in payments from pharmaceutical and medical device companies, with $128.61 received in 2024. These payments were reported across 18 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($404.85).
As a Medicare-enrolled provider, Lafontaine has provided services to 935 Medicare beneficiaries, totaling 985 services with total Medicare billing of $47,950. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location North Providence, RI
- Active Since 02/20/2006
- Last Updated 02/13/2012
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1659346104
Products in Payments
- Xofluza (Drug) $125.19
- RINVOQ (Biological) $103.59
- ArmonAir Digihaler (Drug) $78.47
- UBRELVY (Drug) $25.02
- QULIPTA (Drug) $22.39
- PAXLOVID (Drug) $17.35
- LOKELMA (Drug) $16.86
- MYRISK (Device) $15.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in North Providence
Thomas Hopkins, P.a, P.A
Physician Assistant — Payments: $1,087
Physician Assistant $1,087
Alyssa Friedman, Pa-C, PA-C
Physician Assistant — Payments: $204.47
Physician Assistant $204.47
Ms. Alexa Grande, Pa, PA
Physician Assistant — Payments: $31.18
Physician Assistant $31.18
William Durst, P.a, P.A
Physician Assistant
Physician Assistant
James Cerullo, Pa-C, PA-C
Physician Assistant
Physician Assistant
Ashley Neto, Pa-C, PA-C
Physician Assistant
Physician Assistant